Ontology highlight
ABSTRACT:
SUBMITTER: Bolli R
PROVIDER: S-EPMC5993622 | biostudies-literature | 2018 Jun
REPOSITORIES: biostudies-literature
Bolli Roberto R Hare Joshua M JM March Keith L KL Pepine Carl J CJ Willerson James T JT Perin Emerson C EC Yang Phillip C PC Henry Timothy D TD Traverse Jay H JH Mitrani Raul D RD Khan Aisha A Hernandez-Schulman Ivonne I Taylor Doris A DA DiFede Darcy L DL Lima João A C JAC Chugh Atul A Loughran John J Vojvodic Rachel W RW Sayre Shelly L SL Bettencourt Judy J Cohen Michelle M Moyé Lem L Ebert Ray F RF Simari Robert D RD
Circulation research 20180427 12
<h4>Rationale</h4>Autologous bone marrow mesenchymal stem cells (MSCs) and c-kit<sup>+</sup> cardiac progenitor cells (CPCs) are 2 promising cell types being evaluated for patients with heart failure (HF) secondary to ischemic cardiomyopathy. No information is available in humans about the relative efficacy of MSCs and CPCs and whether their combination is more efficacious than either cell type alone.<h4>Objective</h4>CONCERT-HF (Combination of Mesenchymal and c-kit<sup>+</sup> Cardiac Stem Cell ...[more]